DE3676601D1 - Mittel zur injektion von aktiviertem vitamin-d3. - Google Patents
Mittel zur injektion von aktiviertem vitamin-d3.Info
- Publication number
- DE3676601D1 DE3676601D1 DE8686306652T DE3676601T DE3676601D1 DE 3676601 D1 DE3676601 D1 DE 3676601D1 DE 8686306652 T DE8686306652 T DE 8686306652T DE 3676601 T DE3676601 T DE 3676601T DE 3676601 D1 DE3676601 D1 DE 3676601D1
- Authority
- DE
- Germany
- Prior art keywords
- agents
- injection
- activated vitamin
- vitamin
- activated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003795 chemical substances by application Substances 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19473485 | 1985-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3676601D1 true DE3676601D1 (de) | 1991-02-07 |
Family
ID=16329343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686306652T Expired - Lifetime DE3676601D1 (de) | 1985-09-05 | 1986-08-28 | Mittel zur injektion von aktiviertem vitamin-d3. |
Country Status (4)
Country | Link |
---|---|
US (1) | US4948788A (de) |
EP (1) | EP0215596B1 (de) |
JP (1) | JPS62149619A (de) |
DE (1) | DE3676601D1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2525478B2 (ja) * | 1989-03-01 | 1996-08-21 | 帝人株式会社 | 安定性の改良された活性型ビタミンd▲下3▼類固型製剤 |
JPH02240024A (ja) * | 1989-03-13 | 1990-09-25 | Ss Pharmaceut Co Ltd | 活性型ビタミンd↓3類製剤用組成物 |
US5258375A (en) * | 1989-03-13 | 1993-11-02 | Ss Pharmaceutical Co., Ltd. | Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate |
JP2845342B2 (ja) * | 1990-04-28 | 1999-01-13 | 大正製薬株式会社 | ビタミンd▲下3▼誘導体含有固形製剤組成物 |
JPH04198129A (ja) * | 1990-11-28 | 1992-07-17 | Sumitomo Pharmaceut Co Ltd | 活性型ビタミンd↓3類含有組成物 |
IL103224A (en) * | 1992-09-18 | 1998-08-16 | Teva Pharma | Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3 |
US6274169B1 (en) | 1999-08-02 | 2001-08-14 | Abbott Laboratories | Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol |
US6051567A (en) * | 1999-08-02 | 2000-04-18 | Abbott Laboratories | Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol |
KR100611544B1 (ko) * | 2000-08-30 | 2006-08-10 | 쥬가이 세이야쿠 가부시키가이샤 | 오씨티 제제 |
WO2003047595A1 (en) * | 2001-12-03 | 2003-06-12 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin d compounds |
US7148211B2 (en) * | 2002-09-18 | 2006-12-12 | Genzyme Corporation | Formulation for lipophilic agents |
US20040058895A1 (en) * | 2002-09-18 | 2004-03-25 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
US20040053895A1 (en) * | 2002-09-18 | 2004-03-18 | Bone Care International, Inc. | Multi-use vessels for vitamin D formulations |
WO2004098614A1 (ja) * | 2003-05-07 | 2004-11-18 | Eisai Co., Ltd. | メチルコバラミン含有凍結乾燥製剤及びその製造方法 |
US20060189586A1 (en) * | 2003-06-11 | 2006-08-24 | Cleland Jeffrey L | Pharmaceutical compositions comprising active vitamin D compounds |
CA2503087A1 (en) * | 2005-03-30 | 2006-09-30 | Medicure International Inc. | Intravenous formulations of pyridoxal 5'-phosphate and method of preparation |
CA2503099A1 (en) * | 2005-04-18 | 2006-10-18 | Kabushiki Kaisha Yakult Honsha | Pharmaceutical compositions containing camptothecins |
NL1032493C2 (nl) | 2006-09-14 | 2008-03-17 | Johannes Elisabeth Adri Kruijt | Plantcontainer onafhankelijk, inbouwbaar, bewateringsapparaat, bewateringssysteem en groeisysteem voor planten. |
US20100075933A1 (en) * | 2008-07-28 | 2010-03-25 | Sunita Vijay Shelke | Injectable compositions of vitamin d compounds |
JP6851868B2 (ja) * | 2016-03-23 | 2021-03-31 | 株式会社ファンケル | ビタミンd3安定化組成物 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2036890B1 (de) * | 1969-04-15 | 1973-01-12 | Orsymonde | |
US4004003A (en) * | 1974-08-28 | 1977-01-18 | The Upjohn Company | 25-Hydroxycalciferol compounds for treatment of steroid-induced osteoporosis |
US4190666A (en) * | 1975-08-11 | 1980-02-26 | E. I. Du Pont De Nemours And Company | Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones |
US4340592A (en) * | 1980-03-14 | 1982-07-20 | Adibi Siamak A | Nutrient compositions and method of administering the same |
US4308264A (en) * | 1981-01-28 | 1981-12-29 | Abbott Laboratories | Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration |
JPS58118515A (ja) * | 1981-12-29 | 1983-07-14 | Teijin Ltd | 25‐ヒドロキシビタミンd↓3―26,23‐ラクトンを含有する血清カルシュウム低下剤 |
JPS58116413A (ja) * | 1981-12-29 | 1983-07-11 | Nippon Kayaku Co Ltd | 静注用総合ビタミン剤 |
JPS59155309A (ja) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | 活性型ビタミンd↓3類組成物 |
US4665057A (en) * | 1983-03-22 | 1987-05-12 | Deanna Nelson | Nutrient monoesters |
US4530836A (en) * | 1983-05-31 | 1985-07-23 | Amano Pharmaceutical Co., Ltd. | Peptide |
US4501738A (en) * | 1983-06-30 | 1985-02-26 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition containing 24,25-dihydroxycholecalciferol as an active ingredient to treat pain, pyrexia or inflammatory diseases |
JPS6025934A (ja) * | 1983-07-22 | 1985-02-08 | Nippon Oil & Fats Co Ltd | 経管栄養組成物 |
US4740373A (en) * | 1986-05-27 | 1988-04-26 | Usv Pharmaceutical Corporation | Stabilization of multivitamin/trace elements formulations |
-
1986
- 1986-08-25 JP JP61197223A patent/JPS62149619A/ja active Pending
- 1986-08-28 EP EP86306652A patent/EP0215596B1/de not_active Expired
- 1986-08-28 DE DE8686306652T patent/DE3676601D1/de not_active Expired - Lifetime
- 1986-09-05 US US06/904,125 patent/US4948788A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4948788A (en) | 1990-08-14 |
EP0215596A2 (de) | 1987-03-25 |
EP0215596B1 (de) | 1990-12-27 |
JPS62149619A (ja) | 1987-07-03 |
EP0215596A3 (en) | 1987-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3676601D1 (de) | Mittel zur injektion von aktiviertem vitamin-d3. | |
DE3587518T2 (de) | Vorrichtung zur transdermalen Applikation von Medikamenten. | |
DE3684704D1 (de) | Perfluorierung von aethern. | |
FR2585252B1 (fr) | Pousse-seringue | |
DE3688296T2 (de) | Arzneimittel zur behandlung von erbrechen. | |
DE3684108D1 (de) | Zementformende mittel. | |
DE3685384D1 (de) | Vorbereitung von emulsionen. | |
DE3867989D1 (de) | Mittel zur verhinderung von staubbildung. | |
DE3670398D1 (de) | Quelle fluessiger metallionen. | |
DE3675777D1 (de) | Einspritzvorrichtung. | |
DE3689377D1 (de) | Zufallsfolgengeneratoren. | |
FR2590799B1 (fr) | Seringue | |
DE3585722D1 (de) | Geraet zur iontophoretischen verabreichung von medikamenten. | |
ATE112172T1 (de) | Targetformer von antitumor-methyltrithioagenzien. | |
DE3677916D1 (de) | Nachweis von retikulozyten. | |
DE3672134D1 (de) | N-substituierte diphenylpiperidine. | |
BR8602642A (pt) | Valvula de injecao | |
DE3670956D1 (de) | Behandlung von fluessigkeiten. | |
NO164392C (no) | Fremgangsmaate for forbedring av hydrolysert protein. | |
DE3667273D1 (de) | Von hydroxycarbonsaeuren abgeleitete oberflaechenaktive mittel. | |
DE68907083D1 (de) | Abkoemmlinge von 2-cyclopentenon. | |
DE3769843D1 (de) | Mittel zur verhinderung von krustungsbildung. | |
DE59001827D1 (de) | Port zur einspritzung von medikamenten. | |
DE3668116D1 (de) | Zusammensetzung zur behandlung von infektionen. | |
FI852876L (fi) | Anordning foer undervattensarbete. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |